Skip to main content
Signal8

Remmel H. Lawrence

SEC insider (Form 3/4/5 filer). CIK 0001551817. Director at ATOSSA THERAPEUTICS, INC. (ATOS). 3 reported Form 4/5 transactions since Sep 2024; latest on May 12, 2026. Located in SEATTLE, WA.

Companies Remmel H. Lawrence has filed insider reports for

  • ATOSSA THERAPEUTICS, INC. (ATOS): Director
Remmel H. Lawrence profile photo

Remmel H. Lawrence

CIK: 0001551817

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ATOSSA THERAPEUTICS, INC. logo
ATOS

ATOSSA THERAPEUTICS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • ATOSSA THERAPEUTICS, INC. logo
    ATOS

    ATOSSA THERAPEUTICS, INC.

    May 12, 2026
    Award
    Direct
    10K shares-
  • ATOSSA THERAPEUTICS, INC. logo
    ATOS

    ATOSSA THERAPEUTICS, INC.

    May 15, 2025
    Award

    Stock Option (right to buy)

    Direct
    125K shares-
  • ATOSSA THERAPEUTICS, INC. logo
    ATOS

    ATOSSA THERAPEUTICS, INC.

    Mar 26, 2025
    Purchase
    Direct
    10K shares at avg. $0.70$7K

1-3 of 3